Objective:
To analyse the duration of hospital stay of asymptomatic COVID-19 patients in Integrated Medical care of Hydroxychloroquine and Kaba Sura Kudineer (Herbal decoction).
Design:
A retrospective case series of 19 asymptomatic confirmed SARS-Cov-2 patients from District COVID Care Centre, Tirupati, India, between 23rd May to 7th June 2020.
Method:
Clinical data were collected using a standardised case report form containing demographic information, length of hospital stays and Siddha Yakkai Ilakkanam (Body Constitution) from the records. The association between length of hospital stay, age, gender, and Siddha YI after admissions for confirmed patients was compared and analysed by Kaplan Meier survival analysis method.
Result:
Patients in Aiyam group take at least 9 days of hospital stay, 80% take 10 or more days to cure the disease. 71.4% take more than 4 days and 3 days of hospital stay in Azhal and Vali groups, respectively. 75% of females take 9 days or more of hospital stay. 73.3% of males take 9 days or more of hospital stay. The age group, 19-40 years, has a minimum and maximum hospital stay varies from 2-15 days.
Conclusion:
This study explores the significance of integration of Siddha Medicine with Western medicine in the management of SARS Cov-2 infection. It recorded an overall median of 9 days in the length of stay and 8.5 days in overall mean survival time. This study emphasised higher speedy relief comparing Vietnam and China studies. Comparing those studies, the patient taking integrative treatment have savings of 9 days.